Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

NeoGenomics Q3 Adj. EPS $0.03 Beats $0.02 Estimate, Sales $187.797M Beat $183.770M Estimate

Author: Benzinga Newsdesk | October 28, 2025 06:05am
NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.02 by 42.86 percent. This is a 40 percent decrease over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $187.797 million which beat the analyst consensus estimate of $183.770 million by 2.19 percent. This is a 11.90 percent increase over sales of $167.824 million the same period last year.

Posted In: NEO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist